Pectointercostal Fascial Plane Block Versus Transversus Thoracic Plane Block In Adult Cardiac Surgery Patients

Ultrasound Guided Pectointercostal Fascial Plane Block Versus Transversus Thoracic Plane Block In Adult Cardiac Surgery Patients: A Comparative Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05323305

Enrollment

Registered

2022-04-12

Start date

2022-03-30

Completion date

2022-12-31

Last updated

2022-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Post Operative

Keywords

Ultrasound, pectointercostal, Cardiac surgery

Brief summary

The study will be designed to compare the analgesic effect of ultrasound-guided pectointercostal fascial plane block versus tansversus thoracic plane block in adult cardiac surgery.

Detailed description

A prospective study will be carried out in Alexandria Main University Hospitals on 60 adult patients planned for elective cardiac surgery, after approval of the Ethical Committee of Faculty of Medicine, Alexandria, and having an informed written consent taken from patients included in the study. Patients will be categorized into two equal groups; group P (n=30)) will receive ultrasound-guided pectointercostal fascial plane block and group T (n=30) will receive ultrasound-guided transversus thoracic plane block. All patients will receive the ultrasound-guided block after induction of anesthesia and an equal booster dose of the same block before extubation in the ICU. Patients in both groups will also receive an ultrasound-guided bilateral serratus anterior plane block before extubation.

Interventions

PROCEDUREultrasound guided regional block

Bupivacaine injection by the use of ultrasound in the pectointercostal fascial plane in one group and in the trasversus thoracic plane in the other group.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Adult patient. 2. Elective cardiac surgery.

Exclusion criteria

1. Refusal to participate. 2. Redo or urgent cardiac surgery. 3. Local infection of the skin at the site of needle puncture. 4. Allergy to bupivacaine. 5. Coagulation disorders. 6. Clinically significant liver or kidney disease, heart failure, moderate to severe pulmonary hypertension. 7. when extubation is intentionally planned to be delayed

Design outcomes

Primary

Measure	Time frame	Description
the analgesic effectiveness of the two blocks on midline sternotomy pain,	from end of surgery till discharge from ICU (96 hours)	Postoperative pain evaluation after extubation will be done using the Visual Analogue Scale (VAS). a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between 0 no pain and 10 worst pain.

Secondary

Measure	Time frame	Description
pulmonary complications	from end of surgery till discharge from ICU (96 hours)	atelectasis and pneumonia
length of stay in ICU	average 4 days	days from admission till discharge from ICU

Countries

Egypt

Contacts

Primary ContactIslam Omar, MD

i_omar12@alexmed.edu.eg+201227851759

Backup ContactIbrahim Ibrahim, MD

01224336786

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026